European Archives - Page 7 of 1158 - European Medical Journal

Environmental and Social Stressors Accelerate Ageing in Patients with Lung Disease

Air pollution and poverty accelerate ageing and worsen survival in fibrotic lung disease patients, new international epigenetic study reveals.

Drug-Coated Balloons in Percutaneous Coronary Interventions

Paclitaxel stabilises microtubules and arrests the cell cycle at the G2/M phase, leading to cell death,15,16 which thereby suppresses…

Cardiac MRI Enhances Risk Stratification in HFpEF Through RV Strain Metrics

Understand how MRI-derived RV strain predicts outcomes in HFpEF, offering improved risk stratification over traditional metrics.

EAN 2025: Nightmares Linked to Faster Ageing and Premature Mortality

Frequent nightmares accelerate ageing and triple risk of early death, highlighting a new target for preventive healthcare.

Fexuprazan Found as Effective as PPI for Chronic Cough in Patients with GORD

Learn how P-CAB fexuprazan matches PPI effectiveness in managing GERD-related chronic cough in an 8-week clinical trial.

Hip Fracture Recovery in Older Women: Testosterone Falls Short

In the STEP-HI randomized trial, older women recovering from hip fracture saw no added benefit in mobility from combining exercise with testosterone therapy.

Indoor Triggers That Worsen Childhood Asthma

Discover a new study that has assessed the relationship between indoor home environmental exposures and lung function in children with asthma.

Targeted Liver Disease Screening Needed for Patients with Diabetes

The results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver disease is rare.

EAN 2025: Blood Test for Insulin Resistance Predicts Cognitive Decline in Alzheimer’s

A routine blood test for insulin resistance can predict which Alzheimer’s patients are at risk of rapid cognitive decline.

Metabolic Syndrome Drives Degenerative Changes in Psoriatic Arthritis

A long-term PsA study shows metabolic syndrome is tied to degenerative spine changes, but not joint damage, offering new insight into managing comorbidities.